Lifecore Total Current Liabilities vs Short Long Term Debt Total Analysis
LFCR Stock | 5.91 0.15 2.48% |
Lifecore Biomedical financial indicator trend analysis is infinitely more than just investigating Lifecore Biomedical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lifecore Biomedical is a good investment. Please check the relationship between Lifecore Biomedical Total Current Liabilities and its Short Long Term Debt Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.
Total Current Liabilities vs Short Long Term Debt Total
Total Current Liabilities vs Short Long Term Debt Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lifecore Biomedical Total Current Liabilities account and Short Long Term Debt Total. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Lifecore Biomedical's Total Current Liabilities and Short Long Term Debt Total is 0.81. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of Lifecore Biomedical, assuming nothing else is changed. The correlation between historical values of Lifecore Biomedical's Total Current Liabilities and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Lifecore Biomedical are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Total Current Liabilities i.e., Lifecore Biomedical's Total Current Liabilities and Short Long Term Debt Total go up and down completely randomly.
Correlation Coefficient | 0.81 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Total Current Liabilities
Total Current Liabilities is an item on Lifecore Biomedical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Lifecore Biomedical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Short Long Term Debt Total
Most indicators from Lifecore Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lifecore Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.At this time, Lifecore Biomedical's Selling General Administrative is relatively stable compared to the past year. As of 06/08/2024, Tax Provision is likely to grow to about 363.5 K, while Enterprise Value Over EBITDA is likely to drop 7.98.
2021 | 2023 | 2024 (projected) | Total Revenue | 185.8M | 103.3M | 98.1M | Interest Expense | 17.4M | 18.2M | 19.1M |
Lifecore Biomedical fundamental ratios Correlations
Click cells to compare fundamentals
Lifecore Biomedical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lifecore Biomedical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 541.3M | 502.9M | 295.2M | 295.4M | 255.2M | 248.0M | |
Short Long Term Debt Total | 221.1M | 221.4M | 153.2M | 153.1M | 112.7M | 65.2M | |
Other Current Liab | 19.0M | 20.3M | 16.9M | 17.1M | 10.8M | 12.6M | |
Total Current Liabilities | 164.4M | 101.9M | 79.2M | 79.4M | 38.8M | 55.0M | |
Total Stockholder Equity | 231.0M | 202.8M | 107.9M | 108.1M | (1.8M) | (1.7M) | |
Property Plant And Equipment Net | 200.0M | 217.7M | 200.4M | 139.0M | 134.6M | 78.2M | |
Net Debt | 220.8M | 220.1M | 151.5M | 151.4M | 93.6M | 98.3M | |
Retained Earnings | 71.2M | 38.6M | (58.9M) | (58.7M) | (176.2M) | (167.4M) | |
Accounts Payable | 54.0M | 51.6M | 47.6M | 15.8M | 22.1M | 23.6M | |
Cash | 1.1M | 360K | 1.3M | 1.6M | 19.1M | 10.9M | |
Non Current Assets Total | 386.1M | 384.2M | 354.6M | 171.4M | 155.9M | 161.1M | |
Non Currrent Assets Other | (9.7M) | (25.3M) | (26.7M) | 3.0M | 3.2M | 3.4M | |
Cash And Short Term Investments | 1.1M | 360K | 1.3M | 1.6M | 19.1M | 13.4M | |
Common Stock Shares Outstanding | 29.2M | 29.3M | 29.5M | 29.5M | 30.0M | 26.2M | |
Liabilities And Stockholders Equity | 541.3M | 502.9M | 295.2M | 295.4M | 255.2M | 248.0M | |
Non Current Liabilities Total | 145.9M | 198.3M | 108.0M | 107.9M | 218.2M | 229.1M | |
Inventory | 66.3M | 69.7M | 66.8M | 67.0M | 45.4M | 26.8M | |
Other Current Assets | 8.3M | 14.2M | 7.4M | 7.1M | 5.1M | 8.8M | |
Other Stockholder Equity | 160.3M | 162.6M | 165.5M | 167.4M | 174.3M | 121.7M | |
Total Liab | 310.3M | 300.1M | 187.2M | 187.3M | 257.0M | 269.8M | |
Total Current Assets | 157.1M | 148.3M | 123.7M | 124.0M | 99.3M | 86.9M | |
Short Term Debt | 61.8M | 93.4M | 32.9M | 45.6M | 1.8M | 1.7M | |
Net Receivables | 76.2M | 70.0M | 48.2M | 48.3M | 29.7M | 35.3M | |
Intangible Assets | 45.2M | 38.1M | 36.1M | 15.6M | 4.2M | 4.0M | |
Current Deferred Revenue | 499K | 352K | 1.1M | 919K | 4.1M | 4.3M | |
Good Will | 54.5M | 76.7M | 69.4M | 13.9M | 16.0M | 15.2M | |
Accumulated Other Comprehensive Income | 64K | (2.8M) | (1.4M) | (586K) | (39.2M) | (37.3M) | |
Other Liab | 14.6M | 11.3M | 422K | 3.5M | 3.1M | 3.0M | |
Net Tangible Assets | 123.6M | 143.2M | 78.5M | (19.9M) | (17.9M) | (17.0M) | |
Other Assets | 2.2M | 157.7M | 3.0M | 3.2M | 3.7M | 3.5M | |
Long Term Debt | 101.4M | 164.9M | 97.6M | 101.3M | 116.5M | 121.5M | |
Capital Lease Obligations | 30.8M | 27.5M | 15.0M | 11.0M | 9.9M | 14.1M | |
Net Invested Capital | 421.4M | 396.7M | 246.1M | 99.9M | 89.9M | 85.4M | |
Short Long Term Debt | 89.0M | 29M | 40.6M | 488K | 439.2K | 417.2K | |
Non Current Liabilities Other | 4.6M | 3.6M | 190K | 3.1M | 2.8M | 2.1M | |
Net Working Capital | (7.3M) | 46.4M | 44.5M | 60.5M | 69.6M | 73.0M | |
Property Plant Equipment | 217.7M | 137.4M | 139.0M | 134.6M | 121.1M | 132.6M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.